In the G 1 phase of the mammalian cell cycle, a bi-stable steady state dynamics of the transcription factor E2F ensures that only a certain threshold level of the growth factor can induce a high expression level (on state) of E2F to initiate either normal or abnormal cellular proliferation or even apoptosis. A group of microRNA's known as the mir-17-92 cluster, which specifically inhibits E2F, can simultaneously influence the threshold level of growth factor required for E2F activation, and the corresponding expression level of E2F in the on state. However, mir-17-92 cluster can function as either oncogene or tumor suppressor in a cell-type specific manner for reasons that still remain illusive. Here we put forward a deterministic mathematical model for Myc/E2F/mir-17-92 network that demonstrates how the experimentally observed mir-17-92 mediated differential nature of the cellular proliferation can be reconciled by having conflicting steady state dynamics of E2F for different cell types.
Introduction
In mammalian cells, the expression levels of the key transcription factors E2F (mainly E2F1, E2F2 and E2F3) and Myc precisely govern the fate commitment of a mammalian cell toward either active cellular proliferation or quiescence under normal growth condition in the late G 1 phase of the cell cycle [1] [2] [3] [4] . Experimentally, it had been elegantly demonstrated that the expression level of the E2F1 protein follows a bi-stable dynamics (involving E2F1 and Myc) as a function of growth factor [1] . This implies that based on the expression levels of E2F1 in the late G 1 phase, the mammalian cells can either opt for a quiescence state (Off state, low E2F1 expression) or can decide to go for the normal cell cycle (On state, high E2F1 expression). Fascinatingly, if the E2F1 protein level reaches very high expression level (On state) at relatively lower growth factor stimulation then the cells can even commit for apoptosis [1, 2] . Whereas, an intermediate high expression level of E2F1 (between On state of normal cell cycle and apoptosis cases) maintained for an inbetween threshold growth factor level can eventually lead to uncontrolled cellular proliferation or cancer [2] . Thus, finding out means to control the E2F1 dynamics in and around G 1 /S transition can be crucial from the therapeutic point of view.
In this regard, exploring the role of microRNA's related to the mir-17-92 cluster seems worthwhile, as these microRNA's are well-known antagonist of the E2F genes [5] [6] [7] [8] [9] [10] . The mir-17-92 cluster consists of 7 different microRNA's (mir-17-5p, mir-17-3p, mir-18a, mir-19a, mir-20a, mir-19b-1 and mir-92a-1), and is probably the most well studied microRNA cluster in the literature [5] [6] [7] [8] [9] [10] . Several microRNAs associated with the mir-17-92 cluster play decisive roles in organizing the normal development as well as the events controlling the cellular proliferation in various cell types [11] . Like all the other microRNA's, the members of the mir-17-92 cluster function post-transcriptionally by forming complexes with the mRNA's of different target genes like E2F to either degrade or to reduce the translational efficiency of the corresponding target mRNA's [2, 12] . This seems to suggest that down regulating mir-17-92 cluster components may lead to unwanted cell cycle entry or cancer (as E2F levels will be high) at a lower threshold level of growth factor, which was indeed observed for many hematopoietic cancers [5, 11, 13, 14] . Interestingly, for different solid type cancers, the microRNA's of the mir-17-92 cluster were found to be mostly over-expressed [11, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . This indicates that in solid cancer cells, the expression level of E2F must increase with the increasing level of microRNA's related to mir-17-92 cluster. In this article, we want to rationalize this mir-17-92 cluster mediated differential dynamics of E2F protein in different cancer types, as it may provide us with crucial insights to prevent uncontrolled cellular proliferation and unwanted apoptosis events in a cell type dependent manner. Disentangling the influence of mir-17-92 cluster on the cell type specific differential dynamics of E2F is not a straightforward problem. In fact, in mammalian cells, if we only focus on the mir-17-92 cluster mediated E2F1 dynamics, we will observe that it is tightly regulated by a number of feedback loops operative within a core network of Myc/E2F1/mir-17-92 [1, 2, [31] [32] [33] (Fig. 1) . It is well known that E2F1 can positively regulate its own as well as Myc transcription [2, 33] . Fig. 1 further depicts that both Myc and E2F1 can act as transcription factors for several microRNAs of mir- cluster, which in turn inhibit E2F1 [2, 10, [34] [35] [36] [37] . This clearly suggests that in mammalian cells, either with or without mutation (or non-functional form) of Rb (Retinoblastoma protein, the main antagonist of E2F1), the cell fate decisions during G1-S transition can be modified by altering the expression level of mir-17-92 cluster 
The Myc/E2F1/mir-17-92 model:
To develop our mathematical model, we have expanded the minimal gene regulatory network of Myc/E2F1/mir-17-92 shown in Fig. 1 by incorporating the crucial interactions based on existing experimental literature (Fig. 2) . The model depicts that 
Additional algebraic relations
We have translated the regulatory network shown in Fig. 2 into an ordinary differential equation based mathematical model ( Table 1 ). The variables are defined in Table S1 , and the definitions of the parameters along with their numerical values are provided in Table S2 . We have acquired some of the parameter values directly from experimental literature [1, 31, [38] [39] [40] [41] [42] [43] (shown in Table S2 ). It is worthwhile to mention that here we mainly focus to understand the emergent dynamic behavior of the regulatory network described in Fig 
Results

E2F1 dynamics is indeed differentially regulated by mir-17-92 cluster components in a cell-type specific manner
To begin with, the bifurcation analysis of the model (Table 1) of GF (compared to WT). At this point, we fixed the GF level to 1 s.u., and showed ( Fig. 3b ) that for a cell type represented by a parameter set provided in Table S2 , the steady state level of total E2F1 will increase with the increasing level of mir expression level. Fig. 3a -b resembles the kind of dynamics one observes in the cases of solid tumor cancer cells [11, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . with a fixed level of growth factor (GF = 2 s.u.). Parameters values are as given in Table S2 , with only
The question remains, how we can reverse the phenomenon keeping the same structure of the Myc/E2F1/mir-17-92 network. In this endeavor, we performed the bifurcation analysis after only changing the kinetic parameter k dmp (from 0.01 hr -1 to 0.15 hr -1 ) that represents the rate at which mir facilitates the degradation of the E2F1 mRNA from the Mpi complex. In Fig. 3c , the WT again represents the bi-stable switching E2F1 protein dynamics as a function of GF for a wild type situation of another specific cell type. Interestingly, an increase in the mir expression level now reduces the E2F1 steady state level (situations (ii) and (iii) in Fig. 3c ) in the ON state by even creating a higher threshold value of GF for reaching the ON state as well. On the other hand, a decrease in the mir expression ( Fig. 3c(i) ) is elevating the propensity for proliferation by reducing the threshold requirement of GF. The bifurcation diagram (Fig.3d) of total E2F1 as a function of basal synthesis rate of mir further indicates that for a fixed GF level (2 s.u.), the increasing expression level of mir will decrease the E2F1 in this scenario. This fits the experimental observations found in some hematopoietic cancer cell types as well as for cells where, the mir-17-92 cluster components are found to act in an anti-apoptotic manner [5, 11, 13, 14] .
The model validates the cell type dependent differential dynamics of E2F1
Next, we tried to validate our model outputs with the experimentally known phenotypes under two different scenarios discussed in the previous section. Cloonan et al. [44] have shown that only overexpressing a single micro-RNA (mir-17-5p) related to mir-17-92 cluster is sufficient to drive the HEK293T cells (solid tumor) into high level of proliferation. The MTT assay performed by them [44] revealed that the HEK293T cells became highly proliferative when mir-17-5p was stably overexpressed. At the same time, qRT-PCR experiment confirmed that the E2F1 expression level also increases significantly at the mRNA level [44] . Table S2 ).
Our model simulations (with k dmp 0.01 hr -1 ) predict that in comparison to the WT case, overexpressing the mir-17-92 component elevates the level of E2F1 mRNA (Fig. 4a, left panel) up to an extent observed in the experiments [44] . Interestingly, the temporal evolution dynamics of E2F1 protein (Fig. 4a, right panel) under mir-17-92 overexpression condition seems to correlate nicely with proliferation profile observed in the MTT assay performed by Cloonan et al. [44] .
On the other hand, it has been observed experimentally in case of Hela cells [35] , transient overexpression of the mir-17 cluster has little or no effect on the E2F1 mRNA expression, but it decreases the E2F1 protein expression by about 50%. Our model simulations (with k dmp 0.15 hr -1 ) suggest that the E2F1 protein level can be reduced to 50% of that of the WT situation by overexpressing the mir-17-92 level (Fig. 4b, right panel) . Under the same condition the mRNA level of the E2F1 shows very little effect (Fig. 4b, left panel) . This further emphasizes that mir-17-92 can either enhance or reduce the extent of proliferation by just differentially altering the E2F1 dynamics in a cell type dependent fashion.
Two-parameter bifurcation analysis unravels the dynamical origin of differential dynamics of E2F1
In Fig. 3 and Fig. 4 , we have shown that just by altering k dmp i.e., the microRNA mediated degradation rate of E2F1 mRNA, it is possible to rationalize the differential E2F1 dynamics. To understand how the changes in the parameter k dmp affects such an interesting dynamical transition, we performed a two-parameter bifurcation analysis of the model ( Consequently, the mir-17-92 down-regulated phenotype will commit to proliferation even at lower level of GF compare to the WT (as observed in some cases of hematopoietic cancer [5, 11, 13, 14] ).
We have shown further that even by altering the translational efficiency (k ep2 ) of the mir-17-92 bound E2F1 mRNA (Fig. S1 ), the cell type dependent E2F1 dynamics can also be reconciled. The important question one can ask is whether it is possible to manipulate either k dmp or k ep2 experimentally to influence the cell fate decisionmaking process or not? In our model, the way we modeled the microRNA and E2F1 mRNA interaction is quite simplified in nature. In literature it is already established that microRNAs need the presence of Argonaute proteins (especially Ago2 protein in mammalian cells) to either degrade mRNAs following different degradation pathways or even reducing the translational efficiency of the mRNAs by localizing them into Pbodies [45] . Thus, by either overexpressing or knocking down the Ago2 protein depending on the cell type, we can influence the commitment towards proliferation by altering the E2F1 dynamics.
Myc gene related phenotypes could be reconciled for different levels of mir-17-92
Our minimal model of Myc/E2F1/mir-17-92 network is constructed in such a way that it allows us to investigate the importance of the Myc in the network. Experimentally it has been observed that for conditional lymphoma and leukemic cell lines, overexpressing the microRNAs from mir-17-92 cluster can rescue the cells where, Myc gene expression is temporarily inactivated upon doxycycline treatment [46] . Our model simulation (Fig. 6a, upper panel) shows that once the Myc gene expression is switched off, the relative E2F1 protein expression level falls off very rapidly in 3-4 days time as observed in the experiments [46] for the control cells kept under a basal GF medium. Intriguingly, if the mir-17-92 is overexpressed in the model as soon as the Myc gene is repressed, the relative E2F1 protein level seems to increase gradually (Fig. 6a, lower panel) with time corroborating the experimental findings [46] .
Our model further describes a Myc phenotype, which is even more challenging to envisage. It has been displayed experimentally [42] that overexpressing Myc gene systematically in serum starved REF52 cells containing a d2GFP reporter driven by E2F1 promoter produces a unique phenotype where, for very low and very high level of Myc gene expression, one can have relatively low level of E2F1 protein expression, but a moderate level of Myc expression leads to high expression level of E2F1. The steady state analysis of our model suggests that for such serum starved cells (kept under GF = 0.0001 s.u.), the E2F1 steady state will produce a mushroom like bifurcation (Fig. 6b) as a function of the basal synthesis rate of the Myc. (Table S2) can be varied experimentally to reduce the association propensity of mir and mRNA of E2F1 and (iii) k mr1 and k mr2 can be manipulated by blocking the transcription initiation sites or reducing the level of other transcriptional co-activator require for mir production. Thus, the model qualitatively predicts a set of selective routes to control the proliferation by just perturbing the Myc/E2F1/mir-17-92 network.
Discussion and Conclusions
In many cancerous cells, the principle inhibitor of E2F1 i.e., the Retinoblastoma protein (Rb) remains either as mutated or non-functional [17] . [11, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . In the latter case the experiments further suggest that the apoptosis is caused due to increased expression of E2F1 protein upon down regulating the mir-20a and mir-17-5p [34] .
Importantly, the 2D-bifurcation diagrams ( Fig. 5 and Fig. S1(b) ) reveal the one of the probable routes by which the reversal of the E2F1 steady state dynamics can be achieved under overexpressing condition of mir, and how it can be realized by just altering the k dmp or k ep2 . Intriguingly, the sensitivity analysis (Fig. 7) of the model uncovers that the reversal of the E2F1 dynamics can only be accomplished by changing the mir-17-92 related parameters. We further discussed how one could perform experiments at different levels to test these predictions. In this context, it is worthwhile mentioning that our model definitely improves the current understanding about the Myc/E2F1/mir-17-92 network than the previous model proposed by Aguada et al. [2] . Although their model was a simpler one compare to us, but it failed to portray how the steady state behavior of E2F1 protein can vary in an opposite manner (as a function of GF) as the mir is overexpressed in a cell type dependent manner. Not only that, our model has a broader applicability, as it also adequately explains the Myc related mutants (Fig. 6 ) under different expression levels of mir [42, 46] .
To conclude, our proposed model effectively replicates the mir-17-92 influenced steady state dynamics of E2F1 in a cell-type dependent manner. It predicts exactly how one can manipulate the mir related part of the Myc/E2F1/mir-17-92 network to push a particular cancerous cell to either quiescence or apoptosis. Thus, it provides important insights to utilize the oncogenic or tumor suppressor behavior of mir-17-92
cluster in a context dependent manner for developing novel therapeutic strategies to treat uncontrolled proliferation.
Methods
Deterministic analysis
The complete gene regulatory network ( Fig. 1 ) was constructed in terms of 7 ordinary differential equations. The deterministic bifurcation analysis of the model was executed using the freely available software XPP-AUT. The bifurcation diagrams and time profiles were drawn in Origin Lab using the data points generated by XPP-AUT.
In the systematic sensitivity analysis section, each parameter was increased individually at an amount of 10% with respect to the values given in Table S2 ). Other parameters are same as in Table S2 . To draw the bifurcation diagram of total E2F1
protein as a function of b myc (Fig. 6b ) k ep2 = 0.014 hr -1 , k em2 = 0.03 hr -1 , k mr1 = 0.9 hr -1 and GF = 0.0001 s.u. are used.
